Series A - Eiger BioPharmaceuticals - Apr 15, 2011 Funding Round Profile - Cointime

Bitcoin $79,600.28 +4.18%
Ethereum $3,195.98 +5.10%
BNB $635.34 +2.74%
Optimism $1.69 +5.79%
Arbitrum $0.64 +6.91%
Solana $206.71 +4.13%
Polygon $0.41 +7.22%
Cosmos $5.32 +13.45%
Avalanche $31.98 +11.03%

Bitcoin $79,600.28 +4.18%
Ethereum $3,195.98 +5.10%
BNB $635.34 +2.74%
Optimism $1.69 +5.79%
Arbitrum $0.64 +6.91%
Solana $206.71 +4.13%
Polygon $0.41 +7.22%
Cosmos $5.32 +13.45%
Avalanche $31.98 +11.03%

Eiger BioPharmaceuticals

company

Funding Round

Series A

Money Raised

$ 14.46M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
InterWest Partners	-	-	-	Detail
Vivo Capital	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Feb 25, 2009	Series A	$ 8.30M	InterWest Partners,Vivo Capital	Detail
Jan 1, 2007	Seed	0	RA Capital Management	Detail